158 related articles for article (PubMed ID: 35186599)
21. PAX5 aberrant expression incorporated in MIPI-SP risk scoring system exhibits additive value in mantle cell lymphoma.
Zhang X; Han Y; Nie Y; Jiang Y; Sui X; Ge X; Liu F; Zhang Y; Wang X
J Mol Med (Berl); 2023 May; 101(5):595-606. PubMed ID: 37126184
[TBL] [Abstract][Full Text] [Related]
22. Mantle cell lymphoma with aberrant expression of CD10.
Zanetto U; Dong H; Huang Y; Zhang K; Narbaitz M; Sapia S; Kostopoulos I; Liu H; Du MQ; Bacon CM
Histopathology; 2008 Jul; 53(1):20-9. PubMed ID: 18518902
[TBL] [Abstract][Full Text] [Related]
23. Mantle cell lymphoma with a unique pattern of CD5 expression: a case report with review of the literatures.
Yamada T; Goto N; Tsurumi H; Takata K; Sato Y; Yoshino T; Moriwaki H; Kito Y; Takeuchi T; Iwata H
Med Mol Morphol; 2014 Sep; 47(3):169-75. PubMed ID: 24166616
[TBL] [Abstract][Full Text] [Related]
24. SOX11-negative Mantle Cell Lymphoma: Clinicopathologic and Prognostic Features of 75 Patients.
Xu J; Wang L; Li J; Saksena A; Wang SA; Shen J; Hu Z; Lin P; Tang G; Yin CC; Wang M; Medeiros LJ; Li S
Am J Surg Pathol; 2019 May; 43(5):710-716. PubMed ID: 30768440
[TBL] [Abstract][Full Text] [Related]
25. Clinical and biological features of mantle cell lymphoma patients with co-expression of CD10 and BCL-6: a retrospective study.
Chen W; Liu H; Wang P; Li G
Transl Cancer Res; 2021 Nov; 10(11):4786-4793. PubMed ID: 35116331
[TBL] [Abstract][Full Text] [Related]
26. An uncommon case of de novo CD10+ CD5- mantle cell lymphoma mimics follicle center B cell lymphoma.
Zapata M; Budnick SD; Bordoni R; Li S
Int J Clin Exp Pathol; 2010 Mar; 3(4):430-6. PubMed ID: 20490333
[TBL] [Abstract][Full Text] [Related]
27. CD5-negative mantle cell lymphoma resembling extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue : a case report.
Hashimoto Y; Omura H; Tanaka T; Hino N; Nakamoto S
J Clin Exp Hematop; 2012; 52(3):185-91. PubMed ID: 23269078
[TBL] [Abstract][Full Text] [Related]
28. Blastoid Mantle Cell Lymphoma.
Jain P; Wang M
Hematol Oncol Clin North Am; 2020 Oct; 34(5):941-956. PubMed ID: 32861288
[TBL] [Abstract][Full Text] [Related]
29. Cerebrospinal fluid involvement in mantle cell lymphoma.
Valdez R; Kroft SH; Ross CW; Schnitzer B; Singleton TP; Peterson LC; Finn WG
Mod Pathol; 2002 Oct; 15(10):1073-9. PubMed ID: 12379754
[TBL] [Abstract][Full Text] [Related]
30. Cyclin D1-negative blastoid mantle cell lymphoma identified by SOX11 expression.
Zeng W; Fu K; Quintanilla-Fend L; Lim M; Ondrejka S; Hsi ED
Am J Surg Pathol; 2012 Feb; 36(2):214-9. PubMed ID: 22251940
[TBL] [Abstract][Full Text] [Related]
31. Immunophenotypic variations in mantle cell lymphoma.
Gao J; Peterson L; Nelson B; Goolsby C; Chen YH
Am J Clin Pathol; 2009 Nov; 132(5):699-706. PubMed ID: 19846810
[TBL] [Abstract][Full Text] [Related]
32. Mantle cell lymphoma, blastoid variant, diagnosed on the basis of cytomorphology and flow cytometric immunophenotyping of the lymph node aspirate and peripheral blood.
Lee MJ; Kee KH; Jeon HJ
J Korean Med Sci; 2002 Apr; 17(2):173-8. PubMed ID: 11961299
[TBL] [Abstract][Full Text] [Related]
33. Aberrant expression of CD10 and BCL6 in mantle cell lymphoma.
Pizzi M; Agostinelli C; Righi S; Gazzola A; Mannu C; Galuppini F; Fassan M; Visentin A; Piazza F; Semenzato GC; Rugge M; Sabattini E
Histopathology; 2017 Nov; 71(5):769-777. PubMed ID: 28628241
[TBL] [Abstract][Full Text] [Related]
34. Primary cutaneous blastoid mantle cell lymphoma-case report.
Estrozi B; Sanches JA; Varela PC; Bacchi CE
Am J Dermatopathol; 2009 Jun; 31(4):398-400. PubMed ID: 19461249
[TBL] [Abstract][Full Text] [Related]
35. Toward a Risk-Tailored Therapeutic Policy in Mantle Cell Lymphoma.
Condoluci A; Rossi D; Zucca E; Cavalli F
Curr Oncol Rep; 2018 Aug; 20(10):79. PubMed ID: 30132080
[TBL] [Abstract][Full Text] [Related]
36. Clinicopathologic features and management of blastoid variant of mantle cell lymphoma.
Shrestha R; Bhatt VR; Guru Murthy GS; Armitage JO
Leuk Lymphoma; 2015; 56(10):2759-67. PubMed ID: 25747972
[TBL] [Abstract][Full Text] [Related]
37. Follicular lymphoma with progression to diffuse large B-cell lymphoma and concurrent CD5-negative mantle cell lymphoma-3 entities in a lymph node.
Trimaldi JA; Bowers JW; Bello C; Sagatys EM
Cancer Control; 2014 Jul; 21(3):251-4. PubMed ID: 24955711
[TBL] [Abstract][Full Text] [Related]
38. Classification of small B-cell lymphoid neoplasms using a paraffin section immunohistochemical panel.
Chen CC; Raikow RB; Sonmez-Alpan E; Swerdlow SH
Appl Immunohistochem Mol Morphol; 2000 Mar; 8(1):1-11. PubMed ID: 10937042
[TBL] [Abstract][Full Text] [Related]
39. Ki-67 Labeling Indices in 'Classic' versus 'Blastoid' Mantle Cell Lymphomas--Proposed Cutoff Values for Routine Diagnostic Workup.
Pervez S; Haroon S; Awan D
Asian Pac J Cancer Prev; 2015; 16(15):6591-4. PubMed ID: 26434879
[TBL] [Abstract][Full Text] [Related]
40. Testicular involvement in mantle cell lymphoma: An analysis of 16 patients.
Alkhalili S; Manogna D; Safah H; Ellent E; Beversdorf W; Arora R; Saba NS
Leuk Res Rep; 2023; 20():100397. PubMed ID: 38053743
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
